Autoimmune hepatitis natural history, complications and prognosis: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Irfan Dotani (talk | contribs) No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Autoimmune hepatitis}} | {{Autoimmune hepatitis}} | ||
{{CMG}} | {{CMG}}; {{AE}} | ||
{{PleaseHelp}} | |||
==Overview== | ==Overview== | ||
| Line 15: | Line 17: | ||
==References== | ==References== | ||
{{Reflist|2}} | |||
[[Category:Needs content]] | [[Category:Needs content]] | ||
[[Category:Disease]] | [[Category:Disease]] | ||
[[Category:Gastroenterology]] | [[Category:Gastroenterology]] | ||
[[Category:Needs overview]] | [[Category:Needs overview]] | ||
[[Category: | [[Category:Hepatology]] | ||
{{WS}} | |||
{{WH}} | |||
Revision as of 13:46, 20 July 2016
|
Autoimmune hepatitis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Autoimmune hepatitis natural history, complications and prognosis On the Web |
|
American Roentgen Ray Society Images of Autoimmune hepatitis natural history, complications and prognosis |
|
FDA on Autoimmune hepatitis natural history, complications and prognosis |
|
CDC on Autoimmune hepatitis natural history, complications and prognosis |
|
Autoimmune hepatitis natural history, complications and prognosis in the news |
|
Blogs on Autoimmune hepatitis natural history, complications and prognosis |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:
Please help WikiDoc by adding content here. It's easy! Click here to learn about editing.
Overview
Natural History
Complications
Prognosis
- The prognosis is generally thought to be inversely correlated with the histologic severity of disease.
- Approximately 50% of patients will remain in remission or have only mild disease when steroids are withdrawn after the initial therapy.
- Most patients, however, will require long-term maintenance therapy.